Wedbush Research Analysts Raise Earnings Estimates for Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) – MarketBeat

Share Article

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:

Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) – Wedbush boosted their Q1 2023 earnings estimates for shares of Petco Health and Wellness in a report released on Monday, December 6th. Wedbush analyst S. Basham now expects that the company will post earnings per share of $0.16 for the quarter, up from their prior estimate of $0.11. Wedbush has a “Outperform” rating and a $23.00 price target on the stock. Wedbush also issued estimates for Petco Health and Wellness’ Q2 2023 earnings at $0.26 EPS and Q3 2023 earnings at $0.22 EPS.
Several other research analysts have also recently issued reports on WOOF. Robert W. Baird reiterated a “buy” rating on shares of Petco Health and Wellness in a report on Tuesday, August 17th. Jefferies Financial Group lowered Petco Health and Wellness from a “buy” rating to a “hold” rating and set a $26.00 price objective for the company. in a research note on Monday, November 15th. Credit Suisse Group raised Petco Health and Wellness from a “neutral” rating to an “outperform” rating and set a $28.00 target price for the company in a research report on Friday, August 20th. Evercore ISI reaffirmed a “buy” rating on shares of Petco Health and Wellness in a research report on Sunday, August 22nd. Finally, UBS Group reduced their price objective on Petco Health and Wellness from $27.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday, August 20th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, Petco Health and Wellness presently has a consensus rating of “Hold” and an average target price of $26.00.
NASDAQ WOOF opened at $19.46 on Tuesday. Petco Health and Wellness has a one year low of $17.82 and a one year high of $31.08. The company has a 50-day simple moving average of $22.55 and a 200-day simple moving average of $22.07. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.33 and a current ratio of 0.96. The firm has a market capitalization of $4.41 billion and a PE ratio of 40.54. Petco Health and Wellness (NASDAQ:WOOF) last posted its earnings results on Wednesday, November 17th. The company reported $0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.02. Petco Health and Wellness had a net margin of 2.30% and a return on equity of 8.27%. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.37 billion. The business’s revenue was up 14.6% compared to the same quarter last year.
In other Petco Health and Wellness news, CFO Brian Larose purchased 5,125 shares of the firm’s stock in a transaction on Monday, December 6th. The stock was purchased at an average cost of $19.45 per share, for a total transaction of $99,681.25. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 0.02% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of WOOF. Vanguard Group Inc. increased its stake in Petco Health and Wellness by 44.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,809,223 shares of the company’s stock worth $152,595,000 after purchasing an additional 2,087,179 shares during the period. Wells Fargo & Company MN increased its stake in Petco Health and Wellness by 169.0% during the 2nd quarter. Wells Fargo & Company MN now owns 4,966,303 shares of the company’s stock valued at $111,294,000 after purchasing an additional 3,120,200 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Petco Health and Wellness by 5.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 4,214,757 shares of the company’s stock valued at $94,453,000 after purchasing an additional 217,717 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Petco Health and Wellness by 16.3% in the second quarter. Franklin Resources Inc. now owns 3,550,885 shares of the company’s stock worth $79,575,000 after acquiring an additional 497,196 shares during the period. Finally, BlackRock Inc. grew its stake in shares of Petco Health and Wellness by 11.5% in the second quarter. BlackRock Inc. now owns 3,047,544 shares of the company’s stock worth $68,296,000 after acquiring an additional 313,463 shares during the period. Institutional investors and hedge funds own 63.86% of the company’s stock.
About Petco Health and Wellness
Petco Health and Wellness Company, Inc operates as a retailer of premium pet consumables, supplies, and companion animals and services. The company also offers grooming, in-store and online training, tele-veterinarian, and pet health insurance services, as well as veterinary services through Vetco clinics.
Recommended Story: Upside/Downside Explanation
Earnings History and Estimates for Petco Health and Wellness (NASDAQ:WOOF)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Petco Health and Wellness, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Petco Health and Wellness wasn’t on the list.
While Petco Health and Wellness currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
 
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Each market day you’ll get a one-minute market summary to help you invest wisely.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits
MarketBeat is accredited by the Better Business Bureau
© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness